Literature DB >> 24464784

Polymeric implants for the delivery of green tea polyphenols.

Pengxiao Cao1, Jeyaprakash Jeyabalan, Farrukh Aqil, Srivani Ravoori, Ramesh C Gupta, Manicka V Vadhanam.   

Abstract

Polymeric implants (millirods) have been tested for local delivery of chemotherapeutic agents in cancer treatment. Modeling of drug release profiles is critical as it may provide theoretical insights on rational implant design. In this study, a biodegradable poly (ε-caprolactone) (PCL) polymeric implant delivery system was tested to deliver green tea polyphenols (GTPs), both in vitro and in vivo. Factors including polymer compositions, supplements, drug loads, and surface area of implants were investigated. Our data showed that GTPs were released from PCL implants continuously for long durations, and drug load was the main determining factor of GTPs release. Furthermore, rates of in vitro release and in vivo release in the rat model followed similar kinetics for up to 16 months. A mathematical model was deduced and discussed. GTP implants have the potential to be used systemically and locally at the tumor site as an alternative strategy.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  antioxidants; bioavailability; green tea polyphenols; in vitro/in vivo correlations; polymeric drug delivery systems; preclinical pharmacokinetics; toxicology

Mesh:

Substances:

Year:  2014        PMID: 24464784      PMCID: PMC4009679          DOI: 10.1002/jps.23864

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  27 in total

Review 1.  Advancing the field of drug delivery: taking aim at cancer.

Authors:  Marsha A Moses; Henry Brem; Robert Langer
Journal:  Cancer Cell       Date:  2003-11       Impact factor: 31.743

Review 2.  EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment.

Authors:  Di Chen; Sheng Biao Wan; Huanjie Yang; Jian Yuan; Tak Hang Chan; Q Ping Dou
Journal:  Adv Clin Chem       Date:  2011       Impact factor: 5.394

3.  Local delivery of doxorubicin for the treatment of malignant brain tumors in rats.

Authors:  Maciej S Lesniak; Urvashi Upadhyay; Rory Goodwin; Betty Tyler; Henry Brem
Journal:  Anticancer Res       Date:  2005 Nov-Dec       Impact factor: 2.480

4.  Antitumor efficacy and local distribution of doxorubicin via intratumoral delivery from polymer millirods.

Authors:  Brent D Weinberg; Hua Ai; Elvin Blanco; James M Anderson; Jinming Gao
Journal:  J Biomed Mater Res A       Date:  2007-04       Impact factor: 4.396

5.  Combined tumor therapy by using radiofrequency ablation and 5-FU-laden polymer implants: evaluation in rats and rabbits.

Authors:  John R Haaga; Agata A Exner; Yadong Wang; Nicholas T Stowe; Peter J Tarcha
Journal:  Radiology       Date:  2005-10-19       Impact factor: 11.105

Review 6.  Naturally occurring phytochemicals for the prevention of Alzheimer's disease.

Authors:  Jiyoung Kim; Hyong Joo Lee; Ki Won Lee
Journal:  J Neurochem       Date:  2009-12-26       Impact factor: 5.372

Review 7.  Green tea and cardiovascular disease: from molecular targets towards human health.

Authors:  Nicoline Jochmann; Gert Baumann; Verena Stangl
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-11       Impact factor: 4.294

Review 8.  Poly-epsilon-caprolactone microspheres and nanospheres: an overview.

Authors:  V R Sinha; K Bansal; R Kaushik; R Kumria; A Trehan
Journal:  Int J Pharm       Date:  2004-06-18       Impact factor: 5.875

9.  Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro.

Authors:  Jerry McLarty; Rebecca L H Bigelow; Mylinh Smith; Don Elmajian; Murali Ankem; James A Cardelli
Journal:  Cancer Prev Res (Phila)       Date:  2009-06-19

10.  Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy.

Authors:  Phillip B Storm; John L Moriarity; Betty Tyler; Peter C Burger; Henry Brem; Jon Weingart
Journal:  J Neurooncol       Date:  2002-02       Impact factor: 4.130

View more
  1 in total

1.  Application of red clover isoflavone extract as an adjuvant in mice.

Authors:  Hongbo Chen; Xue Zhang; Longsi Liu; Mingqin Cai; Zhijun Guo; Longxin Qiu
Journal:  Exp Ther Med       Date:  2019-12-11       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.